SCHEMBL1472952

SCHEMBL1472952

Cc1ccccc1-c1ccccc1C#N

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.67
LRRK2 Q5S007 1/20 0.49
AR P10275 2/20 0.49
ESR2 Q92731 1/20 0.48
LMNA P02545 1/20 0.46
NPC1 O15118 1/20 0.43
CASP3 P42574 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
CNR2 P34972 1/20 0.40
KDM4E B2RXH2 1/20 0.40
GALR3 O60755 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
USP8 P40818 1/20 0.39
USP7 Q93009 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29412287 0.85 ESR2 (0.60) TSHRARESR2KDM4EALDH1A1
SCHEMBL20405268 0.85 ESR2 (0.63) TSHRLRRK2ARESR2LMNA
SCHEMBL222 0.85 ESR2 (0.60) TSHRARESR2KDM4EALDH1A1
SCHEMBL21189098 0.84 TSHR (0.57) TSHRLRRK2ARESR2LMNA
SCHEMBL17033197 0.84 TSHR (0.57) TSHRLRRK2ARESR2LMNA
SCHEMBL18406710 0.84 TSHR (0.57) TSHRLRRK2ARESR2LMNA
SCHEMBL9313227 0.84 TSHR (0.57) TSHRLRRK2ARESR2LMNA
SCHEMBL15536685 0.83 TSHR (0.61) TSHRLRRK2ARESR2LMNA
SCHEMBL1132593 0.83 TSHR (0.61) TSHRLRRK2ARESR2LMNA
SCHEMBL29293789 0.82 TSHR (0.50) TSHRLRRK2ARLMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747238-A1 PROCESS FOR PREPARING INTERMEDIATES OF SARTAN ACTIVE COMPOUNDS Sanofi (FR) 2026-05-27 EP claimed
CN-121586706-A Process for the preparation of intermediates for sartan active compounds 赛诺菲 2026-02-27 CN claimed
WO-2025021696-A1 PROCESS FOR PREPARING INTERMEDIATES OF SARTAN ACTIVE COMPOUNDS SANOFI (FR) 2025-01-30 WO claimed
CN-118084811-B Environment-friendly preparation method of sun-screening agent intermediate RET 安庆科思化学有限公司 2024-07-30 CN claimed
CN-118084811-A Environment-friendly preparation method of sun-screening agent intermediate RET 安庆科思化学有限公司 2024-05-28 CN claimed
EP-2194050-A1 A new process for the preparation of irbesartan KRKA, tovarna zdravil, d.d., Novo mesto (SI) 2010-06-09 EP claimed
US-6153810-A Highly selective process for making o-arylbenzonitriles OCCIDENTAL CHEMICAL CORPORATION (US) 2000-11-28 US claimed
US-5874606-A Process for making o-arylbenzonitriles OCCIDENTAL CHEMICAL CORPORATION (US) 1999-02-23 US claimed
WO-1993014086-A1 SUBSTITUTED 1-ISOQUINOLONE DERIVATIVES AS ANGIOTENSIN II ANTAGONISTS SYNTEX (U.S.A.) INC. (US) 1993-07-22 WO claimed
EP-4747238-A1 PROCESS FOR PREPARING INTERMEDIATES OF SARTAN ACTIVE COMPOUNDS Sanofi (FR) 2026-05-27 EP disclosed
CN-121586706-A Process for the preparation of intermediates for sartan active compounds 赛诺菲 2026-02-27 CN disclosed
WO-2025021696-A1 PROCESS FOR PREPARING INTERMEDIATES OF SARTAN ACTIVE COMPOUNDS SANOFI (FR) 2025-01-30 WO disclosed
CN-118510512-A Novel process for the preparation of 4'- (bromomethyl) [1,1' -biphenyl ] -2-carbonitrile 阿尔第实业有限公司 2024-08-16 CN disclosed
CN-118084811-B Environment-friendly preparation method of sun-screening agent intermediate RET 安庆科思化学有限公司 2024-07-30 CN disclosed
EP-0628046-A1 TRIAZOLOPYRIMIDIN DERIVATIVES AS ANTIOTENSIN II RECEPTOR ANTAGONISTS LABORATOIRES UPSA (FR) 1994-12-14 EP disclosed
WO-1993017023-A1 PYRAZOLOPYRIMIDIN DERIVATIVES AS ANGIOTENSIN II RECEPTOR ANTAGONISTS LABORATOIRES UPSA (FR) 1993-09-02 WO disclosed
WO-1993017024-A1 TRIAZOLOPYRIMIDIN DERIVATIVES AS ANTIOTENSIN II RECEPTOR ANTAGONISTS LABORATOIRES UPSA (FR) 1993-09-02 WO disclosed
CN-1055925-A Pyridine derivate and preparation method thereof ICI PLC (GB) 1991-11-06 CN disclosed
EP-0415886-A2 Aza compounds CIBA-GEIGY AG (CH) 1991-03-06 EP disclosed
EP-0253310-A2 Angiotensin II receptor blocking imidazoles E.I. DU PONT DE NEMOURS AND COMPANY (US) 1988-01-20 EP disclosed